Single vs Tandem ASCT in Patients With Newly Diagnosed Multiple Myeloma With High-Risk Cytogenetics
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM)
Leukemia and Lymphoma 2022 Sep 20;[EPub Ahead of Print], A Villalba, AP Gonzalez-Rodriguez, J Arzuaga-Mendez, N Puig, M Arnao, JM Arguiñano, M Jimenez, M Canet, AI Teruel, M Sola, FJ Díaz, C Encinas, A Garcia, L Rosiñol, A Suárez, MS Gonzalez, I Izquierdo, MT Hernández, MS Infante, MJ Sánchez, A Sampol, J de la RubiaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.